Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
2004622 citationsMarc Lacroix, Guy LeclercqBreast Cancer Research and Treatmentprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Guy Leclercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Leclercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Leclercq more than expected).
This network shows the impact of papers produced by Guy Leclercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Leclercq. The network helps show where Guy Leclercq may publish in the future.
Co-authorship network of co-authors of Guy Leclercq
This figure shows the co-authorship network connecting the top 25 collaborators of Guy Leclercq.
A scholar is included among the top collaborators of Guy Leclercq based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Guy Leclercq. Guy Leclercq is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lacroix, Marc & Guy Leclercq. (2004). Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update. Breast Cancer Research and Treatment. 83(3). 249–289.622 indexed citations breakdown →
4.
Jindal, Dharam Paul, et al.. (2003). Synthesis and biological activity of 16-arylidene derivatives of estrone and estrone methyl ether. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 42(1). 166–172.5 indexed citations
Gupta, R., et al.. (1999). Synthesis and biological activity of some D-ring modified estrone derivatives. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 38(5). 563–571.5 indexed citations
7.
Leclercq, Guy, et al.. (1996). Translation: Here and There, Now and Then. Medical Entomology and Zoology.1 indexed citations
Cazaux, Pierre, Guy Leclercq, Alec Vahanian, et al.. (1989). [Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases].. PubMed. 82(12). 1967–71.2 indexed citations
Chesné, Christophe, et al.. (1986). Synthesis and biological studies of aminoestradiol-platinum (II) conjugates. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 21(4). 321–327.19 indexed citations
13.
Leclercq, Guy, Hans Bojar, J Goussard, et al.. (1986). Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.. PubMed. 46(8 Suppl). 4233s–4236s.73 indexed citations
Leclercq, Guy, André Danguy, & Jean-Claude Heuson. (1984). MXT mouse mammary tumour: Growth inhibition by tamoxifen or oestrogen administration. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 12(3). 218–219.1 indexed citations
16.
Leclercq, Guy, Robert Paridaens, & Jean-Claude Heuson. (1984). Relation entre les récepteurs d'oestrogènes et de progestérone et la réponse à l'hormonothérapie. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 60(21). 1521–1528.3 indexed citations
17.
Leclercq, Guy, André Danguy, & Jean-Claude Heuson. (1982). MXT mouse mammary tumor: Effect of ovariectomy on estrogen receptors and histopathology. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 10(1). 71–72.6 indexed citations
18.
Devleeschouwer, N., Guy Leclercq, & Jean-Claude Heuson. (1981). Effect of CB 154 (2-Br-α-Ergocryptine) on MXT mammary tumor growth. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 9(3). 199.1 indexed citations
19.
Devleeschouwer, N., Guy Leclercq, & Jean-Claude Heuson. (1980). Antagonism of cyclofenil and nafoxidine in the growth of the human breast cancer cell line MCF-7. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 8(11). 849.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.